NASDAQ:SEER Seer (SEER) Stock Price, News & Analysis $2.30 +0.29 (+14.43%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$2.21 -0.09 (-3.91%) As of 08/8/2025 06:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Seer Stock (NASDAQ:SEER) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Seer alerts:Sign Up Key Stats Today's Range$1.97▼$2.3050-Day Range$1.96▼$2.3052-Week Range$1.59▼$2.63Volume692,113 shsAverage Volume94,442 shsMarket Capitalization$135.40 millionP/E RatioN/ADividend YieldN/APrice Target$3.00Consensus RatingHold Company Overview Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. Read More Seer Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks39th Percentile Overall ScoreSEER MarketRank™: Seer scored higher than 39% of companies evaluated by MarketBeat, and ranked 689th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingHold Consensus RatingSeer has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageSeer has received no research coverage in the past 90 days.Read more about Seer's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Seer are expected to decrease in the coming year, from ($1.42) to ($1.66) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Seer is -1.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Seer is -1.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSeer has a P/B Ratio of 0.42. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.50% of the float of Seer has been sold short.Short Interest Ratio / Days to CoverSeer has a short interest ratio ("days to cover") of 7.1.Change versus previous monthShort interest in Seer has recently increased by 1.73%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSeer does not currently pay a dividend.Dividend GrowthSeer does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted5.50% of the float of Seer has been sold short.Short Interest Ratio / Days to CoverSeer has a short interest ratio ("days to cover") of 7.1.Change versus previous monthShort interest in Seer has recently increased by 1.73%, indicating that investor sentiment is decreasing. News and Social Media1.7 / 5News Sentiment0.05 News SentimentSeer has a news sentiment score of 0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Seer this week, compared to 5 articles on an average week. Company Ownership3.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Seer insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $62,926.00 in company stock.Percentage Held by Insiders11.28% of the stock of Seer is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions75.20% of the stock of Seer is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Seer's insider trading history. Receive SEER Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Seer and its competitors with MarketBeat's FREE daily newsletter. Email Address SEER Stock News HeadlinesAI Seer’s ArAIstotle Launches to Rewire Truth in Web3August 8 at 5:33 PM | msn.comSeer Inc (SEER) Q2 2025: Everything You Need To Know Ahead Of EarningsAugust 7 at 6:42 AM | finance.yahoo.comMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.August 9 at 2:00 AM | American Alternative (Ad)Seer reiterates $17M–$18M revenue target for 2025 amid macro headwinds and new Proteograph ONE launchAugust 7 at 6:42 AM | msn.comSeer, Inc. (SEER) Q2 2025 Earnings Call TranscriptAugust 7 at 4:00 AM | seekingalpha.comSeer (SEER) Q2 Revenue Jumps 32%August 7 at 2:00 AM | fool.comSeer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 OutlookAugust 6 at 4:05 PM | globenewswire.comInspired By Premanand Govind Sharan, Boy, 13, Flees Home To Become SeerAugust 5, 2025 | msn.comSee More Headlines SEER Stock Analysis - Frequently Asked Questions How have SEER shares performed this year? Seer's stock was trading at $2.31 at the beginning of the year. Since then, SEER stock has decreased by 0.4% and is now trading at $2.30. How were Seer's earnings last quarter? Seer, Inc. (NASDAQ:SEER) released its earnings results on Wednesday, August, 6th. The company reported ($0.33) EPS for the quarter, beating the consensus estimate of ($0.39) by $0.06. The business had revenue of $4.05 million for the quarter, compared to the consensus estimate of $3.75 million. Seer had a negative net margin of 506.15% and a negative trailing twelve-month return on equity of 24.34%. Read the conference call transcript. When did Seer IPO? Seer (SEER) raised $150 million in an initial public offering on Friday, December 4th 2020. The company issued 8,800,000 shares at $16.00-$18.00 per share. J.P. Morgan, Morgan Stanley, BofA Securities and Cowen acted as the underwriters for the IPO. Who are Seer's major shareholders? Seer's top institutional shareholders include Geode Capital Management LLC (0.87%). Insiders that own company stock include Omid Farokhzad, David R Horn, Elona Kogan, Elona Esq Kogan, Scott D Thomas and Dipchand Nishar. View institutional ownership trends. How do I buy shares of Seer? Shares of SEER stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Seer own? Based on aggregate information from My MarketBeat watchlists, some other companies that Seer investors own include fuboTV (FUBO), NIO (NIO), Advanced Micro Devices (AMD), Peloton Interactive (PTON), Tesla (TSLA) and Lemonade (LMND). Company Calendar Last Earnings8/06/2025Today8/09/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:SEER CIK1726445 Webwww.seer.bio Phone650-453-0000FaxN/AEmployees160Year FoundedN/APrice Target and Rating Average Price Target for Seer$3.00 High Price Target$3.00 Low Price Target$3.00 Potential Upside/Downside+30.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)($1.39) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$86.60 million Net Margins-506.15% Pretax Margin-559.60% Return on Equity-24.34% Return on Assets-21.82% Debt Debt-to-Equity RatioN/A Current Ratio19.34 Quick Ratio18.81 Sales & Book Value Annual Sales$14.17 million Price / Sales9.56 Cash FlowN/A Price / Cash FlowN/A Book Value$5.54 per share Price / Book0.42Miscellaneous Outstanding Shares58,870,000Free Float52,229,000Market Cap$135.40 million OptionableOptionable Beta1.57 Social Links Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (NASDAQ:SEER) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seer, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Seer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.